Search
Genprex Inc
GNPXAdd to Watchlist
0.576USD
+0.042+7.80%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
6.10MMarket Cap
LossP/E TTM
Risk Assessment
Currency: USD Updated: 2026-07-02The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Biotechnology & Medical Research domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. No risk assessment score is currently available for Genprex Inc. The Biotechnology & Medical Research industry's average is 3.36. The company's beta value is -0.96. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Beta vs S&P 500 index
-0.96
VaR
+11.31%
240-Day Maximum Drawdown
+98.96%
240-Day Volatility
+178.48%
Return
Best Daily Return
60 days
+22.47%
120 days
+27.53%
5 years
+265.62%
Worst Daily Return
60 days
-23.99%
120 days
-23.99%
5 years
-43.39%
Sharpe Ratio
60 days
-3.21
120 days
-1.63
5 years
-0.21
Risk Assessment
Maximum Drawdown
240 days
+98.96%
3 years
+99.96%
5 years
+99.99%
Return-to-Drawdown Ratio
240 days
-0.97
3 years
-0.33
5 years
-0.20
Skewness
240 days
+9.91
3 years
+10.65
5 years
+11.73
Volatility
Realised Volatility
240 days
+178.48%
5 years
+236.11%
Standardised True Range
240 days
+163.33%
5 years
+6462.61%
Downside Risk-Adjusted Return
120 days
-289.64%
240 days
-289.64%
Maximum Daily Upside Volatility
60 days
+85.44%
Maximum Daily Downside Volatility
60 days
+71.49%
Liquidity
Average Turnover Rate
60 days
+2.04%
120 days
+2.56%
5 years
--
Turnover Deviation
20 days
-97.24%
60 days
-95.07%
120 days
-93.83%